EDGAR Filing Documents for 0001193125-23-080477

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-23-080477

Filing Date

2023-03-27

Accepted

2023-03-27 16:20:29

Documents

Effectiveness Date

2023-03-27

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d492639ds8.htm	S-8	41599
2	EX-5.1	d492639dex51.htm	EX-5.1	11823
3	EX-23.1	d492639dex231.htm	EX-23.1	1504
4	EX-FILING FEES	d492639dexfilingfees.htm	EX-FILING FEES	18736
5	GRAPHIC	g492639dsp7.jpg	GRAPHIC	10546
6	GRAPHIC	g492639g0325083649189.jpg	GRAPHIC	1754
	Complete submission text file	0001193125-23-080477.txt		86512

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270869 | Film No.: 23764773
SIC: 2834 Pharmaceutical Preparations